Received: 9 December 2021
Accepted: 17 March 2022
First Online: 8 April 2022
: All experimental protocols were approved by the research and development department of Med Fanavaran Plus Company. As our study did not contain any human subjects and we just used retrospective anonymized data without any interventional effect on diagnosis, treatment or management of patients, there is no need to have an ethical license.
: Not applicable.
: Nasim Sirjani, Shakiba Moradi, Mostafa Ghelich Oghli and Ali Shabanzadeh have affiliation with Med Fanavaran Plus Co. with direct or indirect financial interest in the subject matter discussed in the manuscript.